Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CSPHF - Week In Review: Nikang Raises $200 Million From U.S. And China Investors

CSPHF - Week In Review: Nikang Raises $200 Million From U.S. And China Investors

CStone Pharmaceuticals - Ordinary Shares
  • NiKang Therapeutics, a clinical stage Delaware biotech, raised $200 million in a Series C financing from US and China investors.
  • Esco Lifesciences of Singapore, an Asia-based life sciences tools company, closed an over-subscribed $200 million Series A and crossover round.
  • Suzhou's CStone Pharma reported that its anti-PD-L1 mAb met its primary endpoint in a Phase III trial in patients with stage III NSCLC.

For further details see:

Week In Review: Nikang Raises $200 Million From U.S. And China Investors
Stock Information
Company Name: CStone Pharmaceuticals - Ordinary Shares
Stock Symbol: CSPHF
Market: OTC
Menu
CSPHF CSPHF Quote CSPHF Short CSPHF News CSPHF Articles CSPHF Message Board
Get CSPHF Alerts

News, Short Squeeze, Breakout and More Instantly...